Can giritinib be used alone? How much does it cost per box?

Giritinib, an important AXL receptor tyrosine kinase inhibitor, provides a new treatment option for those patients with relapsed or refractory acute myeloid leukemia. Although this drug is already available in the domestic market, it has not yet been included in the medical insurance system, so patients must bear the full cost of the drug.

The domestically imported version of giritinib40mg21 tablets is priced as high as 25,000 yuan. Giritinib Overseas and Hong Kong version 40mg42 tablets of the original drug, the price is about 9 10,000 yuan; and the European version of 40mg*84 tablets, the price is around 2110,000 yuan.

In addition, many patients will purchase overseas generic versions of gilitinib. In Laos, several well-known pharmaceutical companies such as ASEAN Pharmaceuticals, Daxiong Pharmaceuticals and Lucius Pharmaceuticals have successfully developed generic versions of giritinib and have officially launched them on the market. These generic drugs are available in various strengths, such as 40mg28 tablets, 40mg84 tablets and 40mg*90 tablets, the price is only between 2000 and 5000 yuan, and their pharmaceutical ingredients are basically the same as the original drugs. Of course, patients must go through formal channels when purchasing to ensure the authenticity and safety of the drugs.

Giltinib effectively inhibits the activity of FLT3 and AXL, two kinases that play key roles in certain leukemias and other cancers. After multiple phases of clinical trials, giltinib has a significant therapeutic effect on patients with FLT3 mutated AML. Not only that, whether used alone or in combination with other chemotherapy drugs, it has shown significant efficacy and can effectively improve patients' conditions and extend their survival.